Frontage Holdings Corporation’s $204 Million Initial Public Offering


Shearman & Sterling advised Merrill Lynch Far East Limited and Goldman Sachs (Asia) L.L.C. as joint sponsors and Merrill Lynch (Asia Pacific) Limited, Goldman Sachs (Asia) L.L.C., CLSA Limited and Haitong International Securities Company Limited as joint global coordinators and joint bookrunners on the $204 million global offering and initial public offering of Frontage Holdings Corporation (Frontage) on the Main Board of The Stock Exchange of Hong Kong Limited.

Frontage priced its offering at HK$3.20 (approximately US$0.41) per offer share and offered 501,910,000 global offering shares, subject to the overallotment option.

Founded in 2001, Frontage is a fast-growing contract research organization providing integrated, scientifically driven research, analytical and development services throughout the drug discovery and development process to enable pharmaceutical companies to achieve their drug development goals.

Shearman & Sterling advised Merrill Lynch Far East Limited and Goldman Sachs (Asia) L.L.C. as joint sponsors and Merrill Lynch (Asia Pacific) Limited, Goldman Sachs (Asia) L.L.C., CLSA Limited and Haitong International Securities Company Limited as joint global coordinators and joint bookrunners with a team including Matthew Bersani (Picture), Minkyu Park, Yuanjing Chen, Alan Yeung, Laurence Crouch, Jason Pratt and Hyunsok Lee.

Involved fees earner: Matthew Bersani – Shearman & Sterling; Yuanjing Chen – Shearman & Sterling; Laurence Crouch – Shearman & Sterling; Hyunsok Lee – Shearman & Sterling; Minkyu Park – Shearman & Sterling; Jason Pratt – Shearman & Sterling; Alan Yeung – Shearman & Sterling;

Law Firms: Shearman & Sterling;

Clients: Goldman Sachs (Asia) L.L.C.; Haitong International Securities Group Limited; Merrill Lynch Far East Limited;